Skip to main content
Stuart Spechler, MD, Gastroenterology, Dallas, TX

Stuart Jon Spechler MD

Esophagus Disease


Chief, Division of Gastroenterology Co-Director, Center for Esophageal Diseases Baylor University Medical Center at Dallas Co-Director, Center for Esophageal Research Baylor Scott & White Research Institute

Join to view full profile
  • 3434 Swiss AveSte 200Dallas, TX 75204

  • Phone+1 469-800-7050

  • Fax+1 469-800-7060

Dr. Spechler is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Stuart Spechler is a gastroenterologist based in Dallas, TX, specializing in esophageal disease. He graduated from Boston University School of Medicine in 1974 and completed both his residency and fellowship at the Boston VA Healthcare System. Currently, he serves as the Chief of the Division of Gastroenterology at Baylor University Medical Center. Dr. Spechler has expertise in general gastroenterology, gastroesophageal reflux, pancreatic cancer, and esophageal disease. He has authored multiple publications on esophageal conditions and has been involved in clinical trials focusing on reflux esophagitis, GERD, Barrett's Esophagus, and eosinophilic esophagitis. He is recognized as a Fellow by both the American Gastroenterological Association and the American College of Gastroenterology. In 2026, Dr. Spechler became president of the American Foregut Society, and he received the William Beaumont Prize in Gastroenterology from the American Gastroenterological Association, a prize that honors a senior investigator who has made a major contribution that has significantly advanced care of patients with digestive diseases through clinical or translational research.

Education & Training

  • Boston VA Healthcare System (Brockton-West Roxbury)
    Boston VA Healthcare System (Brockton-West Roxbury)Fellowship, Gastroenterology, 1977 - 1979
  • Boston VA Healthcare System (Brockton-West Roxbury)
    Boston VA Healthcare System (Brockton-West Roxbury)Residency, Internal Medicine, 1974 - 1977
  • Boston University School of Medicine
    Boston University School of MedicineClass of 1974

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1976 - 2027
  • TX State Medical License
    TX State Medical License 1999 - 2027
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Gastroenterology
    American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • Named President American Foregut Society, 2026
  • William Beaumont Prize in Gastroenterology American Gastroenterological Association, 2026
  • Fellow (AGAF) American Gastroenterological Association, 2006

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Can Eosinophilic Esophagitis Cause Achalasia and Other Esophageal Motility Disorders?  
    Stuart Jon Spechler, Rhonda Souza, Nature

Lectures

  • Contemporary Review of PPI Therapy: What You and Your Patients Need to Know 
    AGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/5/2018
  • Proton Pump Inhibitors: What the Internist Needs to Know 
    American Gastroenterological Association (AGA) Institute, San Diego, California - 5/19/2012

Other

Press Mentions

  • AGA Clinical Practice Update Says P-cABs Can Help When Patients Fail PPI Therapy
    AGA Clinical Practice Update Says P-cABs Can Help When Patients Fail PPI TherapyJanuary 10th, 2025
  • Phathom Pharmaceuticals Presents Data on Novel Potassium-Competitive Acid Blocker (PCAB) Vonoprazan from a Range of Studies at Digestive Disease Week® (DDW) 2022
    Phathom Pharmaceuticals Presents Data on Novel Potassium-Competitive Acid Blocker (PCAB) Vonoprazan from a Range of Studies at Digestive Disease Week® (DDW) 2022May 24th, 2022
  • Surgery Helps Tough-to-Treat Acid Reflux
    Surgery Helps Tough-to-Treat Acid RefluxJanuary 11th, 2020

Grant Support

  • Stratification of Cancer Risk in Patients with Non-Dysplastic Barrett's Esophagus using TissueCypher: The SCRiBE studyBAYLOR RESEARCH INSTITUTE2023–2027
  • The Role of APE1/Ref-1 in Reflux-Induced Epithelial-Mesenchymal Transition in Benign Barrett's Metaplasia: A Novel Target for Preventing Recurrent Barrett's Esophagus After Radiofrequency AblationBAYLOR RESEARCH INSTITUTE2020–2025
  • Clinical Studies On Bile Acids In Barrett'S EsophagusVeterans Affairs2011–2012
  • Basic And Clinical Studies On The Role Of Bile Acids In Barrett'S EsophagusNational Cancer Institute2009–2012
  • Clinical Studies On Bile Acids In Barrett'S EsophagusClinical Science Research &Development2009

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: